Open an account

China Pharma Holdings

CPHI · NYSE American

$0.7001−$0.0243 (−3.35%)TodayMarket open · · Delayed 15 min
Prev close $0.7244

About CPHI

China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The company is headquartered in Haikou, Hainan and currently employs 215 full-time employees. The company went IPO on 2000-02-15. The firm is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The firm's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The firm's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The firm mainly operates in the domestic market.

Employees
224
Headquarters
Haikou, Hainan
Listed
Feb 15, 2000
Sector
Health Care
Industry
Pharmaceuticals
Website
chinapharmaholdings.com

CPHI key statistics

Market cap
31.16M
Price-earnings ratio
—
Dividend yield
—
Average volume
9.26M
Volume
28.00K
Open price
$0.7068
High today
$0.73
Low today
$0.6936
52 Week high
$19.19
52 Week low
$0.3818

China Pharma Holdings (CPHI) at a glance

As of Oct 21, 2026, China Pharma Holdings (CPHI) shares are priced at $0.7001, giving the company a market cap of 31.16M.

Today the stock has traded between $0.6936 and $0.73. The current price is 0.9% above the day's low and 4.1% below its high.

Volume so far is 28.00K shares, below the average of 9.26M shares a day.

Over the past year China Pharma Holdings has ranged from $0.3818 to $19.19, and now sits 2% of the way up that range.

China Pharma Holdings met or beat analyst EPS estimates in 3 of the last 8 quarters. In Q3 FY11 it reported $40.00 per share against an estimate of $61.20.

CPHI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 3 of the last 8 quarters, by 4.8% on average.

  1. Q4 FY09: reported $60.00 per share against an estimate of $68.85
  2. Q1 FY10: reported $50.00 per share against an estimate of $56.10
  3. Q2 FY10: reported $60.00 per share against an estimate of $56.10
  4. Q3 FY10: reported $65.00 per share against an estimate of $64.60
  5. Q4 FY10: reported $75.00 per share against an estimate of $79.90
  6. Q1 FY11: reported $50.00 per share against an estimate of $58.65
  7. Q2 FY11: reported $60.00 per share against an estimate of $56.10
  8. Q3 FY11: reported $40.00 per share against an estimate of $61.20

CPHI news

  • Press releasePRNewswire

    China Pharma Holdings, Inc. Announces Closing of $5.0 Million Registered Direct Offering

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Avi Kapoor

    Crude Oil Gains 2%; GE Vernova Shares Fall After Q2 Earnings

  • Avi Kapoor

    Nasdaq Down Over 100 Points; AT&T Shares Gain After Upbeat Earnings

  • Press releasePRNewswire

    China Pharma Announces Pricing of $5 Million Registered Direct Offering

  • Mohd Haider

    China Pharma Holdings Stock Is Trending — CPHI Soars Nearly 700% on Tuesday, Adds 10% After Hours

  • Press releasePRNewswire

    China Pharma Holdings, Inc. Comments on Unusual Market Activity

  • Avi Kapoor

    Why JB Hunt Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Similar companies

Companies in the same industry as China Pharma Holdings

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.